--- title: "BNR: Q2 operating EBITDA surged 41% year-on-year, prompting a raised full-year outlook" type: "News" locale: "en" url: "https://longbridge.com/en/news/295620883.md" description: "Q2 2026 saw a 41% year-on-year increase in operating EBITDA to EUR 463 million, with revenue up 11% to EUR 4.3 billion, driven by strong commercial execution and cost savings. Full-year EBITDA guidance was raised, though macroeconomic and geopolitical uncertainties persist.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source." datetime: "2026-08-12T06:20:15.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295620883.md) - [en](https://longbridge.com/en/news/295620883.md) - [zh-HK](https://longbridge.com/zh-HK/news/295620883.md) generator: "portal-rs" --- # BNR: Q2 operating EBITDA surged 41% year-on-year, prompting a raised full-year outlook Q2 2026 saw a 41% year-on-year increase in operating EBITDA to EUR 463 million, with revenue up 11% to EUR 4.3 billion, driven by strong commercial execution and cost savings. Full-year EBITDA guidance was raised, though macroeconomic and geopolitical uncertainties persist. Based on **Disclaimer** This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source. ### Related Stocks - [BNR.US](https://longbridge.com/en/quote/BNR.US.md) - [BNR.DE](https://longbridge.com/en/quote/BNR.DE.md) ## Related News & Research - [INTEK: Double-digit revenue and EBITDA growth, strategic acquisitions, and a successful listing drove strong H1 2026 results](https://longbridge.com/en/news/297868837.md) - [MEI: Q1 2027 sales up 10% YoY, EBITDA down 13%, FY 2027 guidance affirmed with 8% growth outlook](https://longbridge.com/en/news/297826217.md) - [INTEG_B: Strong sales growth, higher S1 volumes, and positive EBITDA signal accelerating profitability](https://longbridge.com/en/news/297863807.md) - [UBP says geopolitical shocks push Gulf families to tighten liquidity planning](https://longbridge.com/en/news/298004341.md) - [Cosmos Health Q2 2026 adjusted EBITDA loss narrows to $1.13 million; revenue rises 28.8% to $18.99 million vs. year earlier](https://longbridge.com/en/news/297922662.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**